Abstract
Traditional research in neuropsychology has focused on examining how brain lesions or disruption of neurotransmitter systems affect cognition. Although this corpus of work has produced a rich foundation of knowledge about brain-behavior relationships, recent work has extended this focus to study hormonal influences on the brain and cognition. Perhaps the best-known area in this regard has been the effects of sex hormones, such as estrogen and testosterone, on cognition. However, equally exciting advances are being made in a variety of other neuroendocrine systems that illustrate the diversity and extent of hormonal influences on normal cognition and the manner in which neuroendocrine disruption is associated with a variety of disease states. Recent work in two neuroendocrine systems will be described to illustrate the burgeoning field of cognitive neuroendocrinology and the novel methodologies that have been developed or adapted for use in this area. The first line of research describes how disruption of systemic and central glucose metabolism may contribute to cognitive changes in normal and pathological aging. The second area of research involves the study of how stress hormones affect cognition.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bardgett, M. E., Taylor, G. T., Csernansky, J. G., Newcomer, J. W., & Nock, B. (1994). Chronic corticosterone treatment impairs spontaneous alternation behavior in rats. Behavioral and Neural Biology, 61, 186–190.
Bender, B. G., Lerner, J. A., & Poland, J. E. (1991). Association between corticosteroids and psychologic change in hospitalized asthmatic children. Annals of Allergy, 66, 414–419.
Bennett, M. C., Diamond, D. M., Fleshner, M, & Rose, G. M. (1991). Serum corticosterone level predicts the magnitude of hippocampal primed burst potentiation and depression in urethane anesthetized rats. Psychobiology, 19, 301–307.
Benton, A. L., Varney, N. R., & Hamsher, K. (1978). Visuospatial judgement: A clinical test. Archives of Neurology, 35, 364–367.
Bodnoff, S. R., Humphrey, A. G., Lehmann, J. G., Diamone, D. M., Rose, G. M., & Meaney, M. J. (1995). Enduring effects of chronic corticosterone treatment on spatial learning, synaptic plasticity and hippocampal neuropathology in young and mid aged rats. Journal of Neuroscience, 15, 61–69.
Bohus, B., & de Weid, D. (1980). Pituitary adrenal system hormones and adaptive behavior. In I. G. Jones & I. W. Henderson (Eds.), General comparative and clinical endocrinology of the adrenal cortex (pp. 265–347). London: Academic Press.
Borrell, J., De Kloet, E. R., & Bohus, B. (1984). Corticosterone decreases the efficacy of adrenaline to affect passive avoidance retention of adrenalectomized rats. Life Science, 34, 99–105.
Craft, S., Zallen, G., & Baker, L. D. (1992). Glucose and memory in mild senile dementia of the Alzheimer’s type. Journal of Clinical and Experimental Neuropsychology, 14, 253–267.
Craft, S., Dagogo-Jack, S., Wiethop, B., Murphy, C., Nevins, R., Fleischman, S., Rice, V., Newcomer, J., &Cryer, P. E. (1993). The effects of hyperglycemia on memory and hormone levels in mild senile dementia of the Alzheimer’s type: A longitudinal study. Behavioral Neuroscience, 107, 926–940.
Craft, S., Newcomer, J., Kanne, S., Dagogo-Jack, S., Cryer, P. E., Sheline, Y., Luby, J., Dagogo-Jack, A., & Alderson, A. (1996). Memory improvement following induced hyperinsulinemia in Alzheimer’s disease. Neurobiology of Aging, 17(1), 123–130.
Craft, S., Peskind, E., Schwartz, M. W., Schellenberg, G. D., Raskind, M., & Porte, D., Jr. (1998). Cerebrospinal fluid and plasma insulin levels in Alzheimer’s disease: Relationship to severity of dementia and apolipoprotein E genotype. Neurology, 50, 164–168.
Craft, S., Asthana, S., Newcomer, J. W., Wilkinson, C. W., Baker, L. D., Cherrier, M., Tio Matos, I., Lofgreen, C., Latendresse, S., Petrova, A., Plymate, S., Raskind, M., Scroggin, K., & Veith, R. C. (1999). Enhancement of memory in Alzheimer’s disease with insulin and somatostatin, but not glucose. Archives of General Psychiatry, 56, 1135–1140.
Dachir, S., Kadar, T., Robinzon, B., & Levy, A. (1993). Cognitive deficits induced in young rats by long-term corticosterone administration. Behavioral and Neural Biology, 60, 103–109.
deLeon, M. J., McRae, T., Rusinek, H., Covnit, A., DeSanti, S., Tarshish, C., Golomb, J., Volkow, N., Daisley, K., Orentreich, N., & McEwen, B. (1997). Cortisol reduces hippocampal glucose metabolism in normal elderly, but not in Alzheimer’s disease. Journal of Clinical Endocrinology and Metabolism, 82, 3251–3259.
Diamond, D. M., Bennett, M. C., Fleshner, M., & Rose, G. M. (1992). Inverted-U relationship between the level of peripheral corticosterone and the magnitude of hippocampal primed burst potentiation. Hippocampus, 2, 421–430.
Endo, Y., Nishimura, J.-I., & Kimura, F. (1996). Impairment of maze learning in rats following long-term glucocorticoid treatments. Neuroscience Letters, 203, 199–202.
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). “Mini-mental state.” A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Besearch, 12(3), 189–198.
Foy, M. R., Stanton, M. E., Levine, S., & Thompson, R. F. (1987). Behavioral stress impairs long-term potentiation in rodent hippocampus. Behavioral and Neural Biology, 48,138–149.
Gold, P. E., & Stone, W. S. (1988). Neuroendocrine effects on memory in aged rodents and humans. Neurobiology of Aging, 9, 709–717.
Gold, P. E., Vogt, J., & Hall, J. L. (1986). Glucose effects on memory: Behavioral and pharmacological characteristics. Behavioral and Neural Biology, 46, 145–155.
Hoyer, S. (1994). Desensitization of the neuronal insulin receptor as an etiological factor in sporadic late-onset dementia of the Alzheimer type? In K. Iqbal, J. A. Mortimer, B. Winblad, & H. M. Wisniewski (Eds.), Research advances in Alzheimer’s disease and related disorders (pp. 447–451). New York: Wiley.
Horner, H. C., Packan, D. R., & Sapolsky, R. M. (1990). Glucocorticoids inhibit glucose transport in cultured hippocampal neurons and glia. Neuroendocrinology, 52, 57–64.
Kamboh, M. I. (1995). Apolipoprotein E polymorphism and susceptibility to Alzheimer’s disease. Human Biology, 67(2), 195–215.
Jenike, M. A., & Albert, M. S. (1984). The DEX suppression test in patients with presenile and senile dementia of the Alzheimer’s type. Journal of the American Geriatric Society, 32, 441–444.
Keenan, P. A., Jacobson, M. W., Soleymani, R. M., & Newcomer, J. W. (1995). Commonly used therapeutic doses of glucocorticoids impair explicit memory. Annals of the New York Academy of Science, 761, 400–402.
Leloup, C., Arluison, M., Kassis, N., Lepetit, N. K., Cartier, N., Ferre, P., & Penicaud, L. (1996). Discrete brain areas express the insulin-responsive glucose transporter GLUT4. Molecular Brain Research, 38, 45–53.
Lezak, M. D. (1993). Neuropsychological assessment (3rd ed.). New York: Oxford University Press.
Luine, V., Villegas, M., Martinez, C, & McEwen, B. S. (1994). Repeated stress causes reversible impairments of spatial memory performance. Brain Research, 639, 167–170.
Magarinos, A. M., Ferrini, M., & De Nicola, A. F. (1989). Corticosteroid receptors and glucocorticoid content in microdissected brain regions: Correlative aspects. Neuroendocrinology, 50, 673–678.
Manning, C., Ragozzino, M., & Gold, P. E. (1993). Glucose enhancement of memory in patients with probable senile dementia of the Alzheimer’s type. Neurobiological Aging, 14, 523–528.
Mauri, M., Sinforiani, E., Bono, G., Vignati, F., Berselli, M. E., Attanasio, R., & Nappi, G. (1993). Memory impairment in Cushing’s disease. Acta Neurologica Scandinavica, 87, 52–55.
McCall, A. L. (1992). The impact of diabetes on the CNS. Diabetes, 41, 557–570.
McEwen, B. S. (1982). Glucocorticoids and hippocampus: Receptors in search of function. In D. Ganten & D. Pfaff (Eds.), Adrenal actions on brain (pp. 1–18). New York: Springer-Verlag.
Newcomer, J. W., Faustman, W. O., Whiteford, H. A., Moses, J. A., Jr., & Csernansky, J. G. (1991). Symptomatology and cognitive impairment associate independently with post-dexamethasone cortisol concentrations in unmedicated schizophrenic patients. Biological Psychiatry, 29, 855–864.
Newcomer, J. W., Craft, S., Hershey, T., Askins, K., & Bardgett, M. E. (1994). Glucocorticoid-induced impairment in declarative memory performance in adult humans. Journal of Neuroscience, 14, 2047–2053.
Palovcik, R. A., Phillips, M. I., Kappy, M. S., & Raizada, M. K. (1984). Insulin inhibits pyramidal neurons in hippocampal slices. Brain Research, 309, 187–191.
Perret, E. (1974). The left frontal lobe of man and the suppression of habitual responses in verbal categorical behavior. Neuropsychologia, 12, 323–330.
Raichle, M. E., Herscovitch, P., Mintun, M., Martin, W. R., & Powers, W. (1984). Dynamic measurements in the study of higher cortical function in humans with positron emission tomography. Annals of Neurology, 15(Suppl.), S48.
Reul, J. M. H. M., & De Kloet, E. R. (1985). Two receptor systems for corticosterone in rat brain: Microdistribution and differential occupation. Endocrinology, 117, 2505–2511.
Reus, V. I. (1984). Hormonal mediation of the memory disorder in depression. Drug Development Research, 4, 489–500.
Roozendaal, B., & McGaugh, J. L. (1996). Amygdaloid nuclei lesions differentially affect glucocorticoid-induced memory enhancement in an inhibitory avoidance task. Neurobiology of Learning and Memory, 65, 1–8.
Roozendaal, B., & McGaugh, J. L. (1997a). Glucocorticoid receptor agonist and antagonist administration into the basolateral but not central amygdala modulates memory storage. Neurobiology of Learning and Memory, 67, 176–179.
Roozendaal, B., & McGaugh, J. L. (1997b). Basolateral amygdala lesions block the memory-enhancing effect of glucocorticoid administration in the dorsal hippocampus of rats. European Journal of Neuroscience, 9, 76–83.
Shiosaka, S. (1992). Attempts to make models for Alzheimer’s disease [Review]. Neuroscience Research, 13, 237–255.
Squire, L. R. (1992). Memory and the hippocampus: A synthesis of findings with rats, monkeys, and humans. Psychological Review, 99, 195–231.
Starkman, M. N., Schteingart, D. E., & Schork, M. A. (1986). Cushing’s syndrome after treatment: Changes in cortisol and ACTII levels, and amelioration of the depressive syndrome. Psychiatry Research, 19, 177–188.
Stone, W. S., Cotrill, K. L., Walker, D. L., & Gold, P. E. (1988). Blood glucose and brain function: Interactions with CNS cholinergic systems. Behavioral Neural Biology, 50(3), 325–334.
Storandt, M., & Hill, R. D. (1989). Very mild senile dementia of the Alzheimer’s type II. Psychometric test performance. Archives of Neurology, 46, 383–386.
Tierney, M. C., Snow, W. G., Reid, D., Zorzitto, M. L., & Fisher, R. H. (1987). Psychometric differentiation of dementia: Replication and extension of the findings of Stroandt and coworkers. Archives of Neurology, 44, 720–722.
Woolley, C. S., Gould, E., Frankfurt, M., & McEwen, B. S. (1990). Naturally occurring fluctuation in dendritic spine density on adult hippocampal pyramidal neurons. Journal of Neuroscience, 10, 4035–4039.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Craft, S., Newcomer, J. (2001). Cognitive Neuroendocrinology. In: Tarter, R.E., Butters, M.A., Beers, S.R. (eds) Medical Neuropsychology. Critical Issues in Neuropsychology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1287-5_2
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1287-5_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5479-6
Online ISBN: 978-1-4615-1287-5
eBook Packages: Springer Book Archive